As shown in Figure 2, cold tumors are resistant to anti-PD-1 therapy (ICI-resistant) and Wnt/β-catenin signaling inhibition in the tumor microenvironment activates antitumor effector T cells, converting cold tumors to hot tumors (ICI-sensitive) [67]. The gene discussed is PDCD1; the disease is neoplasm.